CliffBio
small molecule

VISUDYNE

VERTEPORFIN

Loss of exclusivity—loss of exclusivity
CompanyBAUSCH AND LOMB IRELAND LTD

Drug detail

Brand nameVISUDYNE
Active ingredientVERTEPORFIN
Strength15MG/VIAL
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalApril 2000
Marketing statusRX

More from BAUSCH AND LOMB IRELAND LTD

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.